A carregar...
Novel glutamatergic drugs for the treatment of mood disorders
Mood disorders are common and debilitating, resulting in a significant public health burden. Current treatments are only partly effective and patients who have failed to respond to trials of existing antidepressant agents (eg, those who suffer from treatment-resistant depression [TRD]) require innov...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3747027/ https://ncbi.nlm.nih.gov/pubmed/23976856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S36689 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|